[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100652662":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":10,"centralContacts":10,"locations":10,"responsibleParty":28,"collaborators":10,"id":30,"slug":31,"hasResults":32,"nctId":33,"briefTitle":34,"officialTitle":35,"acronym":10,"eligibilityCriteria":36,"healthyVolunteers":37,"sex":38,"minAge":39,"maxAge":10,"enrollmentInfo":40,"targetDuration":10,"studyType":43,"phases":10,"briefSummary":44,"conditions":45,"keywords":47,"overallStatus":52,"whyStopped":10,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":10},{"fullName":5,"class":6},"Bühlmann Laboratories AG","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Non-atopic",null,"Healthy non-atopic subjects with no history of allergies",[13],"Diagnostic Test: Basophil activation test",{"label":15,"type":10,"description":16,"interventionNames":17},"Atopic peanut","Atopic subjects with confirmed peanut allergy",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Atopic non-peanut","Atopic subjects with a diagnosed allergy but confirmed negative for peanut allergy",[13],[23],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"DIAGNOSTIC_TEST","Basophil activation test","Flow CAST® is a flow cytometry-based basophil activation test. Whole blood samples from patients are stimulated with specific allergens, as well as stimulation buffer and stimulation controls, to evaluate the patient's basophil degranulation in vitro",[19,15,9],{"type":29,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100652662","flow-cast-peanut-trial-100652662",false,"NCT07775430","Flow CAST® Peanut Trial","Clinical Evaluation of Flow CAST® as an Aid in the Diagnosis of Peanut Allergy","Inclusion Criteria:\n\n* Individual undergoing a blood draw\n* Individual willing and able to provide two additional tubes of blood (3ml each tube) for research purposes\n* Individual or legal guardian will and able to sign the informed consent form to participate in the study\n\nExclusion Criteria:\n\n* Individual has undergone immunotherapy for peanuts or other identified allergens that have been shown to cause allergic symptoms\n* Individual has been exposed to systemically administered glucocorticoids within the last 24 hours.\n* Individual has been recently exposed to small molecule immunosuppressive medications\n* Individual has been recently exposed to treatment with biologics interfering with the type-I allergic pathway\n* Individual is currently involved in another \"allergy treatment related\" clinical research study",true,"ALL","6 Months",{"count":41,"type":42},245,"ESTIMATED","OBSERVATIONAL","This will be a multi-center, prospective evaluation, conducted at a minimum of four (4) U.S. sites. Sites will enroll peanut allergic subjects, subjects with allergies other than peanut and apparently healthy non-atopic control subjects and collect blood samples for testing using Flow CAST® and the comparative ImmunoCAP sIgE test.",[46],"Peanut Allergies",[48,49,50,51],"Food allergy","peanut allergy","allergy","peanut","NOT_YET_RECRUITING","2026-08-17",{"date":55,"type":56},"2026-08-20","ACTUAL",{"date":58,"type":42},"2026-10-01",{"date":60,"type":42},"2027-12-31",{"name":5,"class":6}]